CD8A and cancer: As a result, both spleen-selective LNPs-based mRNA vaccine formulations induced greater CD8+ and CD4+ T cell accumulation compared to PBS controls (Figure S11A-B), indicating that the superior cancer immunotherapy efficacy may be attributed to the changes of microenvironment with enhanced immune cells infiltration.